gvtcx

Framework for the supply of Unlicensed Specials

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,000,000
Statuscomplete
Procedureopen
OCIDocds-h6vhtk-054547

Awards (5)

This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is £1,000,000.

SupplierValueDateStatus
Ascot Laboratories shared £1,000,000 31 Aug 2026 pending
Eaststone Ltd shared £1,000,000 31 Aug 2026 pending
Prulab Pharma Ltd shared £1,000,000 31 Aug 2026 pending
Rosemont Pharmaceuticals Ltd shared £1,000,000 31 Aug 2026 pending
Vertical Pharma Resources Ltd/IPS Pharma shared £1,000,000 31 Aug 2026 pending

description

East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-supplier Framework Agreement on behalf of its member Trusts for the supply of Unlicensed Specials

notice history

5 notices published against this procurement.

PublishedTypeRegimeNotice
9 Jun 2025 Pipeline notice (UK1) Procurement Act 2023 030941-2025
7 Oct 2025 Preliminary market engagement (UK2) Procurement Act 2023 062801-2025
8 Oct 2025 Preliminary market engagement (UK2) Procurement Act 2023 063272-2025
19 Mar 2026 Tender notice (UK4) Procurement Act 2023 025053-2026
1 Sept 2026 Contract award (UK6) Procurement Act 2023 082617-2026

more from University Hospitals of Derby and Burton NHS Foundation Trust

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.